Henry Schein reports record results for Q3 2015

Henry Schein has achieved a record-breaking financial performance for the third quarter of 2015, with a net sales total of $2.7 billion (1.77 billion pounds).

This represented a 2.4 percent year-over-year increase. Its performance reflected accelerated growth in adjusted diluted earnings per share as well as in worldwide sales, despite a negative impact due to the strength of the US dollar.

Dental sales came to $1.3 billion, down by 2.5 percent in nominal terms but reflecting 4.6 percent growth in local currencies when the exchange impact of the US dollar is factored out. Its medical division saw the most pronounced growth of all of its divisions.

Net sales for the first nine months of 2015 were $7.8 billion, an increase of 1.4 percent compared with the corresponding period of 2014.

It has now introduced guidance for 2016 adjusted diluted earnings that represents growth of ten to 12 percent compared with the midpoint of its new 2015 adjusted guidance range.

Stanley Bergman, chairman of the board and chief executive officer of Henry Schein, said: "Through our longstanding strategy of organic growth complemented by strategic acquisitions, we believe we continued to gain market share on an overall basis during the quarter, both in North America and internationally."